Lithium chloride ≥99% GSK3beta inhibitor
Om denne vare
Direct, non-competitive GSK3β inhibitor in vitro(Ki = 2 mM). Elicits various neuropharmacological effects.
: All products are FOR RESEARCH USE ONLY. PRODUCTS ARE NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES. Customer is granted a limited use non-exclusive licence for its own internal research. Any control manufacturer supplies with a Product is limited to use only to validate the relevant Product. By using the Product, Customers agree not to attempt to reverse engineer or otherwise perform any compositional, structural, functional or other analyses directed to learning the methodology, formulae, sequences, processes, make-up or production of any of the Products or portions thereof.
- CAS nummer:7447-41-8
- Molecular Weight:42,39 g/mol
2 tilgængelige muligheder nedenfor
Product Details & Documents
Direct, non-competitive GSK3β inhibitor in vitro(Ki = 2 mM). Elicits various neuropharmacological effects.
: All products are FOR RESEARCH USE ONLY. PRODUCTS ARE NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES. Customer is granted a limited use non-exclusive licence for its own internal research. Any control manufacturer supplies with a Product is limited to use only to validate the relevant Product. By using the Product, Customers agree not to attempt to reverse engineer or otherwise perform any compositional, structural, functional or other analyses directed to learning the methodology, formulae, sequences, processes, make-up or production of any of the Products or portions thereof.
- CAS nummer:7447-41-8
- Molecular Weight:42,39 g/mol
Specifications for Product Family
Specifikationstestresultater
- Constituents::100% Lithium chloride



